首頁 > 市場調查報告書 > 食物/飲料

生鮮食品

全球水產養殖疫苗市場研究報告-行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測

市場調查報告書

商品編碼

1305157

全球水產養殖疫苗市場研究報告-行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測

Global Aquaculture Vaccines Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年06月01日 | 出版商:

Value Market Research | 英文 162 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到2030年，全球水產養殖疫苗市場需求將從2022年的4.2707億美元達到近9.4244億美元，2023-2030年復合年成長率為10.4%。

水產養殖疫苗是專門設計用於水產養殖（養殖魚類、貝類和甲殼類等水生生物）的疫苗。這些疫苗有助於保護養殖的水生生物免受疾病的侵害，這些疾病會降低其健康狀況、生長速度和總體產量。

市場動態：

全球對海產品的需求不斷成長，推動了水產養殖業的發展，同時也帶動了對水產養殖疫苗的需求。隨著該行業的擴大，保護養殖物種健康的需求也隨之增加。水產養殖場疾病爆發頻率的增加突出了對有效疫苗接種計劃的需求。這些疾病的爆發會給養殖戶帶來巨大的經濟損失，並影響養殖物種的健康，進而影響最終產品的品質。疫苗技術的進步導致開發出更有效、更安全的疫苗用於水產養殖。疫苗在水產養殖中的使用已變得越來越普遍，新疫苗也在不斷開發，以預防新的和新出現的疾病。世界各國政府都在為水產養殖業提供支持，包括對疫苗研發的投資。這導致了新疫苗的開發和現有疫苗計劃的擴大。隨著人們對水產養殖中疫苗接種益處的認知不斷提高，預計對水產養殖疫苗的需求將繼續增加。在水產養殖業迅速發展的發展中國家尤其如此。

研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰了解行業結構，評估全球競爭吸引力。此外，這些工具還對全球水產養殖疫苗市場的各個細分市場進行了全面評估。水產養殖疫苗行業的成長和趨勢為本研究提供了整體方法。

市場細分：

水產養殖疫苗市場報告的這一部分提供了國家和地區層面細分市場的詳細數據，從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。

按產品分類

減毒活疫苗
去活化疫苗
亞單位疫苗
DNA疫苗
重組疫苗

按給藥途徑

口服
注射劑
浸泡和噴霧

按應用

細菌
病毒
寄生蟲

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太、拉丁美洲以及中東和非洲地區水產養殖疫苗市場的當前和未來需求。此外，報告還重點介紹了所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。水產養殖疫苗市場的主要參與者包括Zoetis、Phibro Animal Health Corporation、Elanco、Merck & Co.Inc.、KBNP、Cavac、Kyoto Biken Laboratories Inc.、Nisseiken Co.Ltd.、Vaxxinova International BV、Hipra。本部分包括競爭格局的整體觀點，其中包括各種戰略發展，如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

區域展望銷售分析
銷售分析
北美銷售分析
- 概述、歷史和預測銷售分析
- 北美細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測銷售分析
- 歐洲銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測銷售分析
- 亞太地區各細分市場銷售分析
- 亞太地區各國銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 亞太其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測銷售分析
- 中東和非洲各細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第十章: 水產養殖疫苗企業競爭格局

水產養殖疫苗市場競爭
夥伴關係/合作/協議
合併與收購
新產品上市
其他發展

第十一章：公司概況

前10強企業佔有率分析
市場集中率
Zoetis
- 公司概況
- 公司收入
- 產品
- 近期發展
Phibro Animal Health Corporation
- 公司概況
- 公司收入
- 產品
- 近期發展
Elanco
- 公司概況
- 公司收入
- 產品
- 近期發展
Merck & Co. Inc.
- 公司概況
- 公司收入
- 產品
- 近期發展
KBNP
- 公司概況
- 公司收入
- 產品
- 近期發展
Cavac
- 公司概況
- 公司收入
- 產品
- 近期發展
Kyoto Biken Laboratories Inc.
- 公司概況
- 公司收入
- 產品
- 近期發展
Nisseiken Co. Ltd.
- 公司概況
- 公司收入
- 產品
- 近期發展
Vaxxinova International BV
- 公司概況
- 公司收入
- 產品
- 近期發展
Hipra
- 公司概況
- 公司收入
- 產品
- 近期發展

*注：在公司概況中，財務細節和近期發展取決於可用性，如果是私營公司，則可能不包括在內。

簡介目錄圖表

Product Code: VMR112110574

The global demand for Aquaculture Vaccines Market is presumed to reach the market size of nearly USD 942.44 MN by 2030 from USD 427.07 MN in 2022 with a CAGR of 10.4% under the study period 2023 - 2030.

Aquaculture vaccines are vaccines specifically designed for use in aquaculture, the farming of aquatic organisms such as fish, shellfish, and crustaceans. These vaccines help protect farmed aquatic species from diseases and illnesses that can reduce their health, growth, and overall production.

Market Dynamics:

The increasing demand for seafood worldwide is driving the growth of the aquaculture industry and, with it, the demand for aquaculture vaccines. As the industry expands, the need to protect the health of the farmed species increases. The increased frequency of disease outbreaks in aquaculture farms has highlighted the need for effective vaccination programs. These outbreaks can result in significant financial losses for farmers and can affect the health of the farmed species, which in turn can impact the quality of the final product. Advances in vaccine technology have led to the development of more effective and safe vaccines for use in aquaculture. The use of vaccines in aquaculture has become increasingly common, and new vaccines are constantly being developed to protect against new and emerging diseases. Governments around the world are providing support for the aquaculture industry, including investment in the research and development of vaccines. This is leading to the development of new vaccines and the expansion of existing vaccine programs. As awareness of the benefits of vaccination in aquaculture grows, the demand for aquaculture vaccines is expected to continue to increase. This is particularly true in developing countries, where the aquaculture industry is expanding rapidly.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of aquaculture vaccines. The growth and trends of aquaculture vaccines industry provide a holistic approach to this study.

Market Segmentation:

This section of the aquaculture vaccines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines

By Route Of Administration

Oral
Injected
Immersion & Spray

By Application

Bacterial
Viral
Parasitic

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Aquaculture Vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the aquaculture vaccines market include Zoetis, Phibro Animal Health Corporation, Elanco, Merck & Co. Inc., KBNP, Cavac, Kyoto Biken Laboratories Inc., Nisseiken Co. Ltd., Vaxxinova International BV, Hipra. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . AQUACULTURE VACCINES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Route Of Administration
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL AQUACULTURE VACCINES MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Attenuated Live Vaccines Historic and Forecast Sales by Regions
6.5 Inactivated Vaccines Historic and Forecast Sales by Regions
6.6 Subunit Vaccines Historic and Forecast Sales by Regions
6.7 DNA Vaccines Historic and Forecast Sales by Regions
6.8 Recombinant Vaccines Historic and Forecast Sales by Regions

7 . GLOBAL AQUACULTURE VACCINES MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

7.1 Overview by Route Of Administration
7.2 Historical and Forecast Data
7.3 Analysis by Route Of Administration
7.4 Oral Historic and Forecast Sales by Regions
7.5 Injected Historic and Forecast Sales by Regions
7.6 Immersion & Spray Historic and Forecast Sales by Regions

8 . GLOBAL AQUACULTURE VACCINES MARKET SALES ANALYSIS BY APPLICATION

8.1 Overview by Application
8.2 Historical and Forecast Data
8.3 Analysis by Application
8.4 Bacterial Historic and Forecast Sales by Regions
8.5 Viral Historic and Forecast Sales by Regions
8.6 Parasitic Historic and Forecast Sales by Regions

9 . GLOBAL AQUACULTURE VACCINES MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE AQUACULTURE VACCINES COMPANIES

10.1. Aquaculture Vaccines Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF AQUACULTURE VACCINES INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Zoetis
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Phibro Animal Health Corporation
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Elanco
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Merck & Co. Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. KBNP
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Cavac
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Kyoto Biken Laboratories Inc.
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Nisseiken Co. Ltd.
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Vaxxinova International BV
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Hipra
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表